The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Topological Polar Surface Area: A Useful Descriptor in 2D-QSAR
Open accessAbstract
Topological polar surface area (TPSA), which makes use of functional group contributions based on a large database of structures, is a convenient measure of the polar surface area that avoids the need to calculate ligand 3D structure or to decide which is the relevant biological conformation or conformations. We demonstrate the utility of TPSA in 2D-QSAR for 14 sets of diverse pharmacological activity data. Even though a large pool of reports showing the importance of the classic 2D descriptors such as calculated logP (ClogP) and calculated molar refractivity (CMR) exists in the 2D-QSAR literature, this is the first report to demonstrate the value of TPSA as a relevant descriptor applicable to a large, structurally and pharmacologically diverse set of classes of compounds. We also address the limitations of applicability of this descriptor for 2D-QSAR analysis. We observed a negative correlation of TPSA with activity data for anticancer alkaloids, MT1 and MT2 agonists, MAO-B and tumor necrosis factor-alpha inhibitors and a positive correlation with inhibitory activity data for telomerase, PDE-5, GSK-3, DNA-PK, aromatase, malaria, trypanosomatids and CB2 agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TESTING FOR SERIAL CORRELATION IN LEAST SQUARES REGRESSION. II
DURBIN, J., & WATSON, G. S. (1951) · Biometrika · doi:10.1093/biomet/38.1-2.159 · Cited by 3,619
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804011 · Cited by 627
Diversity-oriented synthesis: Exploring the intersections between chemistry and biology
Tan, D. S. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0705-74 · Cited by 605
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980402t · Cited by 519
Substituent constants for correlation analysis
Hansch, C., Rockwell, S. D., Jow, P. Y. C., Leo, A., & Steller, E. E. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00212a024 · Cited by 416
Leahy, J. J. J., Golding, B. T., Griffin, R. J., Hardcastle, I. R., Richardson, C., Rigoreau, L., & Smith, G. C. M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.060 · Cited by 411
Virtual Exploration of the Small‐Molecule Chemical Universe below 160 Daltons
Fink, T., Bruggesser, H., & Reymond, J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462457 · Cited by 353
Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase
Brühlmann, C., Ooms, F., Carrupt, P.-A., Testa, B., Catto, M., Leonetti, F., Altomare, C., & Carotti, A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010894d · Cited by 290
Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T., & Jäger, W. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.08.008 · Cited by 288
Gnerre, C., Catto, M., Leonetti, F., Weber, P., Carrupt, P.-A., Altomare, C., Carotti, A., & Testa, B. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001028o · Cited by 262
Competitive and noncompetitive inhibition of the DNA-dependent protein kinase.
Izzard, R. A., Jackson, S. P., & Smith, G. C. M. (1999) · PubMed · Cited by 203
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
Smith, D. G., Buffet, M., Fenwick, A. E., Haigh, D., Ife, R. J., Saunders, M., Slingsby, B. P., Stacey, R., & Ward, R. W. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00721-6 · Cited by 161
Doweyko, A. M. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-4068-0 · Cited by 135
Factors affecting delivery of antiviral drugs to the brain
Strazielle, N., & Ghersi‐Egea, J. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.454 · Cited by 114
6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Witherington, J. J., Bordas, V., Gaiba, A., Garton, N. S., Naylor, A., Rawlings, A. D., Slingsby, B. P., Smith, D. G., Takle, A. K., & Ward, R. W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00645-0 · Cited by 113
5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Witherington, J. J., Bordas, V., Haigh, D., Hickey, D. M. B., Ife, R. J., Rawlings, A. D., Slingsby, B. P., Smith, D. G., & Ward, R. W. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00135-5 · Cited by 108
IV-IVC considerations in the development of immediate-release oral dosage form
Li, S., He, H., Parthiban, L. J., Yin, H., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20378 · Cited by 105
Liu, R., Sun, H., & So, S. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010290i · Cited by 104
Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors
Manley, P. W., Furet, P., Bold, G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020899q · Cited by 103
Hollick, J. J., Golding, B. T., Hardcastle, I. R., Martin, N. M. B., Richardson, C. J., Rigoreau, L. J. M., Smith, G. C. M., & Griffin, R. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00652-8 · Cited by 102
Liu, R., & So, S. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010289j · Cited by 96
Remko, M., Swart, M., & Bickelhaupt, F. M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.020 · Cited by 93
Correlation of blood–brain penetration using structural descriptors
KATRITZKY, A. R., Kuanar, M., Slavov, S. H., Dobchev, D. A., Fara, D. C., Karelson, M. M., Acree, W. E., Solov’ev, V. P., & Varnek, A. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.012 · Cited by 88
Hollick, J. J., Rigoreau, L. J. M., Cano, C., Cockcroft, X. F., Curtin, N. J., Frigerio, M., Golding, B. T., Guiard, S., Hardcastle, I. R., Hickson, I., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061121y · Cited by 85
Gerebtzoff, G., & Seelig, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0600814 · Cited by 82
Clark, D. E., Higgs, C. J., Wren, S. P., Dyke, H. J., Wong, M. H. L., Norman, D., Lockey, P. M., & Roach, A. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040762v · Cited by 79
Cyclooxygenase (COX) Inhibitors: A Comparative QSAR Study
Garg, R., Kurup, A., Mekapati, S. B., & Hansch, C. H. (2003) · Chemical Reviews · doi:10.1021/cr020464a · Cited by 76
Drug transport and drug resistance in African trypanosomes
Mäser, P., Lüscher, A., & Kaminsky, R. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.09.001 · Cited by 75
Russell, M. G. N., Carling, R. W., Atack, J. R., Bromidge, F. A., Cook, S. M., Hunt, P. A., Isted, C., Lucas, M., McKernan, R. M., Mitchinson, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040883v · Cited by 72
Marrero‐Ponce, Y., Castillo‐Garit, J. A., Torrens, F., Zaldívar, V. R., & Castro, E. A. (2004) · Molecules · doi:10.3390/91201100 · Cited by 72
Quantitative Structure−Activity Relationship Studies on Inhibition of HERG Potassium Channels
Yoshida, K., & Niwa, T. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050450g · Cited by 67
Monge, A., Arrault, A., Marot, C., & Morin‐Allory, L. (2006) · Molecular Diversity · doi:10.1007/s11030-006-9033-5 · Cited by 64
Freitas, M. P. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b516396j · Cited by 64
Catecholic Flavonoids Acting as Telomerase Inhibitors
Menichincheri, M., Ballinari, D., Bargiotti, A., Bonomini, L., Ceccarelli, W., D’Alessio, R., Fretta, A., Moll, J., Polucci, P., Soncini, C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040810b · Cited by 59
Discovery and structure?activity relationship of coumarin derivatives as TNF-$alpha; inhibitors
Cheng, J., Chen, M., Wallace, D., Tith, S., Arrhenius, T. S., Kashiwagi, H., Ono, Y., Ishikawa, A., Sato, H., Kozono, T., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(04)00355-5 · Cited by 54
Pan, D., Iyer, M., Liu, J., Li, Y., & Hopfinger, A. J. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0498057 · Cited by 49
Lavey, B. J., Kozlowski, J. A., Hipkin, R. W., Gonsiorek, W., Lundell, D. J., Piwinski, J. J., Narula, S. K., & Lunn, C. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.007 · Cited by 47
Estrada, E., Quincoces, J., & Patlewicz, G. Y. (2003) · Molecular Diversity · doi:10.1023/b:modi.0000006804.97390.40 · Cited by 43
Sivaprakasam, P., Xie, A., & Doerksen, R. J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.021 · Cited by 42
Self-citationA QSAR Toxicity Study of a Series of Alkaloids with the Lycoctonine Skeleton
Turabekova, M. A., & Rasulev, B. (2004) · Molecules · doi:10.3390/91201194 · Cited by 35
Epperson, J. R., Bruce, M. A., Catt, J. D., Deskus, J. A., Hodges, D. B., Karageorge, G. N., Keavy, D. J., Mahle, C. D., Mattson, R. J., Ortiz, A. A., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.002 · Cited by 16
Telomere dysfunction and telomerase activation in cancer – a pathological paradox?
Calcagnile, O., & Gisselsson, D. (2007) · Cytogenetic and Genome Research · doi:10.1159/000108310 · Cited by 14
Cited by
Polymer Genome: A Data-Powered Polymer Informatics Platform for Property Predictions
Kim, C., Chandrasekaran, A., Huan, T. D., Das, D., & Ramprasad, R. (2018) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b02913 · Cited by 513
Issahaku, A. R., Mukelabai, N., Agoni, C., Rudrapal, M., Aldosari, S. M., Almalki, S. G., & Khan, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-22668-1 · Cited by 93
Metadata
- Authors
- Prasanna, S., & Doerksen, R.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 21-41
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2080447388
- Cited by
- 484
- References
- 44
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.